Filing Details
- Accession Number:
- 0001209191-18-051478
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-09-18 16:33:51
- Reporting Period:
- 2018-09-14
- Accepted Time:
- 2018-09-18 16:33:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1180262 | Herbalife Nutrition Ltd. | HLF | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1311282 | David Pezzullo | 800 W. Olympic Blvd Suite 406 Los Angeles CA 90015 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-09-14 | 33,070 | $55.64 | 157,940 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-09-14 | 63,934 | $22.40 | 221,874 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-09-14 | 25,743 | $55.62 | 196,131 | No | 4 | D | Direct | |
| Common Stock | Disposition | 2018-09-14 | 18,936 | $55.62 | 177,195 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2018-09-14 | 37,528 | $29.99 | 214,723 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-09-14 | 20,235 | $55.62 | 194,488 | No | 4 | D | Direct | |
| Common Stock | Disposition | 2018-09-14 | 8,574 | $55.62 | 185,914 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2018-09-14 | 106,034 | $15.22 | 291,948 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-09-14 | 29,016 | $55.62 | 262,932 | No | 4 | D | Direct | |
| Common Stock | Disposition | 2018-09-14 | 38,187 | $55.62 | 224,745 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2018-09-18 | 66,805 | $55.12 | 157,940 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | D | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | D | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | D | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Appreciation Rights | Disposition | 2018-09-14 | 63,934 | $0.00 | 63,934 | $22.40 |
| Common Stock | Stock Appreciation Rights | Disposition | 2018-09-14 | 37,528 | $0.00 | 37,528 | $29.99 |
| Common Stock | Stock Appreciation Rights | Disposition | 2018-09-14 | 106,034 | $0.00 | 106,034 | $15.22 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-05-31 | 2022-05-31 | No | 4 | M | Direct |
| 0 | 2017-04-30 | 2024-04-30 | No | 4 | M | Direct |
| 0 | 2018-03-02 | 2025-03-02 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 6, 2018.
- This transaction was executed in multiple trades at prices ranging from $55.06 to $56.04. The price reported reflects the weighted average sale price of $55.64. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- On May 14, 2018, the common stock of Herbalife Nutrition Ltd. split 2-for-1, resulting in the reporting person's acquisition of 95,505 additional shares of common stock.
- The reporting person received 19,255 shares of common stock upon the net exercise of 63,934 stock appreciation rights ("SARS"). The reporting person forfeited 25,743 shares of common stock underlying the SARS in payment of the exercise price and 18,936 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on September 14, 2018 of $55.62.
- The reporting person received 8,719 shares of common stock upon the net exercise of 37,528 SARS. The reporting person forfeited 20,235 shares of common stock underlying the SARS in payment of the exercise price and 8,574 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on September 14, 2018 of $55.62.
- The reporting person received 38,831 shares of common stock upon the net exercise of 106,034 SARS. The reporting person forfeited 29,016 shares of common stock underlying the SARS in payment of the exercise price and 38,187 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on September 14, 2018 of $55.62.
- This transaction was executed in multiple trades at prices ranging from $54.65 to $55.59. The price reported reflects the weighted average sale price of $55.12. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- These SARS were previously reported as covering 31,967 shares at an exercise price of $44.79 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018.
- These SARS were previously reported as covering 18,764 shares at an exercise price of $59.98 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018.
- These SARS were previously reported as covering 53,017 shares at an exercise price of $30.44 per share, but were adjusted to reflect the stock split that occurred on May 14, 2018.
Billionaire Hedge Funds
